About: covid:PMC7221328

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7221328 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Zhang, Jie Li, Xingwang Jiang, Rongmeng Li, Jiandong Li, Xiaoguang Zhang, Yongxiang Han, Bing Chen, Jin Liu, Jianhua Song, Meihua Ding, Yanyan Xue, Bing Zhu, Jing Dong, Shuwen Guo, Weian Han, Xuefeng Jin, Xiuhong Nie, Qingrong Shan, Xiaoyin Wang, Baozeng Zhang, Changhong Zhang, Erming Zhang, Zuoqing
is schema:about of	named entity 'recombinant' named entity 'inhalation' named entity 'HUMAN' named entity 'RECOMBINANT' named entity 'viral pneumonia' named entity 'recombinant' named entity 'clinical symptoms' named entity 'adverse events' named entity 'Respiratory Disease' named entity 'antiviral drugs' named entity 'Streptococcus pneumoniae' named entity 'SARS' named entity 'Interferons' named entity 'IFNα' named entity 'treatment of patients' named entity 'adverse events' named entity 'MERS-CoV' named entity 'homologous' named entity 'nebulizers' named entity 'rash' named entity 'biochemical tests' named entity 'CAP' named entity 'cytokines' named entity 'influenza virus' named entity 'lower respiratory tract' named entity 'respiratory rate' named entity 'CAP' named entity 'clinical practice' named entity 'expectoration' named entity 'parainfluenza virus' named entity 'infection' named entity 'cardiac insufficiency' named entity 'control group' named entity 'viruses' named entity 'rales' named entity 'MERS' named entity 'signs and symptoms' named entity 'Prophylactic' named entity 'viral replication' named entity 'infectious disease' named entity 'RNA' named entity 'BMI' named entity 'virus' named entity 'respiratory syncytial virus' named entity 'IFN' named entity 'IFNα' named entity 'increased body temperature' named entity 'United States' named entity 'chest pain' named entity 'avian influenza viruses' named entity 'respiratory rate' named entity '5.7%' named entity 'mucous membranes' named entity 'IFNα' named entity 'chest pain' named entity 'respiratory rate' named entity 'recombinant' named entity 'viral diseases' named entity 'aerosol' named entity 'intramuscular injection' named entity 'pathogens' named entity 'chest pain' named entity '28 days' named entity 'IFN' named entity 'inhalation' named entity 'developing countries' named entity 'open-label trial' named entity 'virus' named entity 'adverse reactions' named entity 'blood pressure' named entity 'clinical laboratory' named entity 'Aerosol' named entity 'viral infections' named entity 'pathogens' named entity 'pneumonia' named entity 'United States' named entity 'neuraminidase inhibitors'

Attributes

Values

Creator

Zhang, Jie
Li, Xingwang
Jiang, Rongmeng
Li, Jiandong
Li, Xiaoguang
Zhang, Yongxiang
Han, Bing
Chen, Jin
Liu, Jianhua
Song, Meihua
Ding, Yanyan
Xue, Bing
Zhu, Jing
Dong, Shuwen
Guo, Weian
Han, Xuefeng
Jin, Xiuhong
Nie, Qingrong
Shan, Xiaoyin
Wang, Baozeng
Zhang, Changhong
Zhang, Erming
Zhang, Zuoqing

is schema:about of

named entity 'recombinant'
named entity 'inhalation'
named entity 'HUMAN'
named entity 'RECOMBINANT'
named entity 'viral pneumonia'
named entity 'recombinant'
named entity 'clinical symptoms'
named entity 'adverse events'
named entity 'Respiratory Disease'
named entity 'antiviral drugs'
named entity 'Streptococcus pneumoniae'
named entity 'SARS'
named entity 'Interferons'
named entity 'IFNα'
named entity 'treatment of patients'
named entity 'adverse events'
named entity 'MERS-CoV'
named entity 'homologous'
named entity 'nebulizers'
named entity 'rash'
named entity 'biochemical tests'
named entity 'CAP'
named entity 'cytokines'
named entity 'influenza virus'
named entity 'lower respiratory tract'
named entity 'respiratory rate'
named entity 'CAP'
named entity 'clinical practice'
named entity 'expectoration'
named entity 'parainfluenza virus'
named entity 'infection'
named entity 'cardiac insufficiency'
named entity 'control group'
named entity 'viruses'
named entity 'rales'
named entity 'MERS'
named entity 'signs and symptoms'
named entity 'Prophylactic'
named entity 'viral replication'
named entity 'infectious disease'
named entity 'RNA'
named entity 'BMI'
named entity 'virus'
named entity 'respiratory syncytial virus'
named entity 'IFN'
named entity 'IFNα'
named entity 'increased body temperature'
named entity 'United States'
named entity 'chest pain'
named entity 'avian influenza viruses'
named entity 'respiratory rate'
named entity '5.7%'
named entity 'mucous membranes'
named entity 'IFNα'
named entity 'chest pain'
named entity 'respiratory rate'
named entity 'recombinant'
named entity 'viral diseases'
named entity 'aerosol'
named entity 'intramuscular injection'
named entity 'pathogens'
named entity 'chest pain'
named entity '28 days'
named entity 'IFN'
named entity 'inhalation'
named entity 'developing countries'
named entity 'open-label trial'
named entity 'virus'
named entity 'adverse reactions'
named entity 'blood pressure'
named entity 'clinical laboratory'
named entity 'Aerosol'
named entity 'viral infections'
named entity 'pathogens'
named entity 'pneumonia'
named entity 'United States'
named entity 'neuraminidase inhibitors'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software